Cardiomyopathies

"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Descriptor ID	D009202
MeSH Number(s)	C14.280.238
Concept/Terms	Cardiomyopathies Cardiomyopathies Cardiomyopathy Myocardial Diseases Disease, Myocardial Diseases, Myocardial Myocardial Disease Myocardiopathies Myocardiopathy Cardiomyopathies, Secondary Cardiomyopathies, Secondary Cardiomyopathy, Secondary Secondary Cardiomyopathies Secondary Cardiomyopathy Secondary Myocardial Diseases Disease, Secondary Myocardial Diseases, Secondary Myocardial Myocardial Disease, Secondary Secondary Myocardial Disease Myocardial Diseases, Secondary Cardiomyopathies, Primary Cardiomyopathies, Primary Cardiomyopathy, Primary Primary Cardiomyopathies Primary Cardiomyopathy Primary Myocardial Diseases Myocardial Diseases, Primary Disease, Primary Myocardial Diseases, Primary Myocardial Myocardial Disease, Primary Primary Myocardial Disease

Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiomyopathies [C14.280.238]

Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.

Bar chart showing 50 publications over 22 distinct years, with a maximum of 5 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2003	1	0	1
2004	1	0	1
2006	2	0	2
2007	2	0	2
2008	2	1	3
2009	1	1	2
2010	1	0	1
2011	2	0	2
2012	2	1	3
2013	3	0	3
2014	1	0	1
2015	2	0	2
2016	3	0	3
2017	1	1	2
2018	4	0	4
2019	5	0	5
2020	3	0	3
2021	2	0	2
2022	3	0	3
2023	3	0	3

Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.

Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.

View in: PubMed
Hara A, Tallquist MD. Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis. Curr Cardiol Rep. 2023 06; 25(6):485-493.

View in: PubMed
Rene C, Faustin M, Bonhomme J, Deschamps MM, Jean-Gilles M, Rosenberg R, Ibrahim M, McNairy M, Pape JW, Devieux JG. An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti. Crit Pathw Cardiol. 2023 03 01; 22(1):19-24.

View in: PubMed
Cobb MS, Tao S, Shortt K, Girgis M, Hauptman J, Schriewer J, Chin Z, Dorfman E, Campbell K, Heruth DP, Shohet RV, Dawn B, Konorev EA. Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts. Am J Physiol Heart Circ Physiol. 2022 12 01; 323(6):H1091-H1107.

View in: PubMed
Umbarkar P, Tousif S, Singh AP, Anderson JC, Zhang Q, Tallquist MD, Woodgett J, Lal H. Fibroblast GSK-3a Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Circ Res. 2022 09 16; 131(7):620-636.

View in: PubMed
Shimada BK, Boyman L, Huang W, Zhu J, Yang Y, Chen F, Kane MA, Yadava N, Zou L, Lederer WJ, Polster BM, Chao W. Pyruvate-Driven Oxidative Phosphorylation is Downregulated in Sepsis-Induced Cardiomyopathy: A Study of Mitochondrial Proteome. Shock. 2022 04 01; 57(4):553-564.

View in: PubMed
Wang X, Costello BT, Papapostolou S, O'Brien J, Taylor A, Zhao S. Differentiating Nonischemic Dilated Cardiomyopathy With Incidental Infarction From Ischemic Cardiomyopathy by Geometric Indices Derived From Cardiovascular Magnetic Resonance. J Thorac Imaging. 2021 Jul 01; 36(4):248-253.

View in: PubMed
Gupta A, Fei YD, Kim TY, Xie A, Batai K, Greener I, Tang H, Ciftci-Yilmaz S, Juneman E, Indik JH, Shi G, Christensen J, Gupta G, Hillery C, Kansal MM, Parikh DS, Zhou T, Yuan JX, Kanthi Y, Bronk P, Koren G, Kittles R, Duarte JD, Garcia JGN, Machado RF, Dudley SC, Choi BR, Desai AA. IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias. Blood. 2021 03 04; 137(9):1208-1218.

View in: PubMed
Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Chen Y, Wilson CL, Estepp J, Rai P, Hankins JS, Burridge PW, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, Mulrooney DA, Yasui Y. Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry. Cancer Res. 2021 05 01; 81(9):2556-2565.

View in: PubMed
Gutman SJ, Kawakami H, Taylor AJ, Marwick TH. The Relationship Between Mechanical Dispersion and Late Gadolinium Enhancement in Patients With Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2020 12; 13(12):2687-2689.

View in: PubMed

People

Explore

Similar Concepts

Top Journals